Agilon Health IncAGL
Price$79.59

Outlook & Key Dates

Estimates, guidance, catalysts, and upcoming events

Analyst Estimates Learn more →
Analyst Coverage
13analysts covering
Consensus: NeutralAs of 18 Aug 2026
FY EPS (est.)
-$1.67next fiscal year
As of 18 Aug 2026
Reporting Calendar
EventExpected Date
Q3 2026 Earnings Release3 Nov 2026
Monitoring Framework
Key Performance Indicators
Total Platform Membership Quarterly536K
Medicare Advantage Membership Quarterly426K
ACO REACH Membership Quarterly110K
Medical Margin Quarterly149MTarget: 350000000 to 400000000
Adjusted EBITDA Quarterly54MTarget: 10000000 to 40000000
Watch Items
  • Medicare Advantage Medical Cost TrendTrigger: Exceeding 7.4% reserve rate or 7.0% full-year outlookAction: Re-evaluate payer contract economics and accelerate clinical pathway programs (CHF, COPD, dementia) to drive downstream cost avoidance.
  • Payer Contract RenewalsTrigger: 50% of contracts open for renewal in 2027Action: Execute disciplined contracting focused on profitability over volume, exiting unprofitable markets or contracts where necessary.
  • Part D Underwriting ExposureTrigger: Exceeding 15% of membershipAction: Continue strategic reduction of Part D exposure to limit underwriting volatility outside of company control.
Sign in / Sign up to read more

Research as of 20 Jun 2026

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.